Furthermore, Cordaro et al. found that dabrafenib-resistant cells increase their motility, despite the EMT markers’ expression remaining unaltered (E-cadherin, Snail) or even decreased (Twist), which suggests a “distinct active EMT-like” process adopted by melanoma cells under drug exposure [17]. This evidence concerns the gene TWIST1 and melanoma.